These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

307 related items for PubMed ID: 37373173

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Compared to the amniotic membrane, Wharton's jelly may be a more suitable source of mesenchymal stem cells for cardiovascular tissue engineering and clinical regeneration.
    Pu L, Meng M, Wu J, Zhang J, Hou Z, Gao H, Xu H, Liu B, Tang W, Jiang L, Li Y.
    Stem Cell Res Ther; 2017 Mar 21; 8(1):72. PubMed ID: 28320452
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Differential expression of cell cycle and WNT pathway-related genes accounts for differences in the growth and differentiation potential of Wharton's jelly and bone marrow-derived mesenchymal stem cells.
    Batsali AK, Pontikoglou C, Koutroulakis D, Pavlaki KI, Damianaki A, Mavroudi I, Alpantaki K, Kouvidi E, Kontakis G, Papadaki HA.
    Stem Cell Res Ther; 2017 Apr 26; 8(1):102. PubMed ID: 28446235
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Human Wharton's jelly mesenchymal stem cells: properties, isolation and clinical applications.
    Borys-Wójcik S, Brązert M, Jankowski M, Ożegowska K, Chermuła B, Piotrowska-Kempisty H, Bukowska D, Antosik P, Pawelczyk L, Nowicki M, Jeseta M, Kempisty B.
    J Biol Regul Homeost Agents; 2017 Apr 26; 33(1):119-123. PubMed ID: 30729769
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Isolation method and xeno-free culture conditions influence multipotent differentiation capacity of human Wharton's jelly-derived mesenchymal stem cells.
    Corotchi MC, Popa MA, Remes A, Sima LE, Gussi I, Lupu Plesu M.
    Stem Cell Res Ther; 2013 Jul 11; 4(4):81. PubMed ID: 23845279
    [Abstract] [Full Text] [Related]

  • 13. Osteogenic differentiation of human mesenchymal stem cells from adipose tissue and Wharton's jelly of the umbilical cord.
    Zajdel A, Kałucka M, Kokoszka-Mikołaj E, Wilczok A.
    Acta Biochim Pol; 2017 Jul 11; 64(2):365-369. PubMed ID: 28600911
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Expression of Galectins in umbilical cord mesenchymal stem cells].
    Li CH, Sun L, Zhang YJ, Zhao JX, Yao ZQ, Xu N, Liu R, Liu XY.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Jun 18; 45(3):452-7. PubMed ID: 23774927
    [Abstract] [Full Text] [Related]

  • 19. The Molecular Regulatory Mechanism in Multipotency and Differentiation of Wharton's Jelly Stem Cells.
    Ma L, He X, Wu Q.
    Int J Mol Sci; 2023 Aug 18; 24(16):. PubMed ID: 37629090
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.